Trial site
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
- 14running trials
- 2closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Ovarian cancer4 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Bladder cancer2 trials
- Cervical cancer2 trials
- Head and neck cancer2 trials
- Liver and biliary tract cancer2 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- and 4 more
- Phase
- Phase 35 trials
- Phase 14 trials
- Phase 23 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Status
- Active, not recruiting9 trials
- Recruiting5 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Bristol-Myers Squibb2 trials
- Boehringer Ingelheim1 trial
- Cullinan Therapeutics Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Active, not recruiting
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Active, not recruiting
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026